(+1) 88 700 600
310 West 14th North Street, NY

Why Pitt?

bt_bb_section_bottom_section_coverage_image

Research at Pitt

Medicine in Pittsburgh

The University of Pittsburgh School of Medicine consistently ranks among the top recipients of NIH funding. In fiscal year 2023, the University received $658 million in NIH awards, placing it 6th nationally, following a ranking of 3rd in 2022 with $675 million. This level of funding supports over 3,400 active research awards and nearly 1,800 principal investigators. The University’s total research expenditures have steadily increased, reaching $1.2 billion in 2024, with approximately $918 million coming from the Health Sciences division alone. As a result, Pitt research contributes over $2.2 billion annually to the Pennsylvania economy.

Working with the VMI

The Vascular Medicine Institute partnered with the UPMC Heart and Vascular Institute to form the Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute in 2013. The institute functions with the goal of performing cutting edge research in hemostasis, red blood cell biophysics, transfusion medicine, cardiovascular biology, mitochondrial biology and nitrite-nitric oxide and reactive oxygen species biochemistry to expand our understanding of the control of blood flow to organ systems and the development of novel therapies for diseases such as pulmonary hypertension, sickle cell vasculopathy, atherosclerosis, hypertension and heart disease. The Vascular Medicine Institute is supported by the University of Pittsburgh, UPMC, Vitalant, and the Hemophilia Center of Western Pennsylvainia.

Partnering with the Center for Mitochondrial Medicine

The Center for Metabolism and Mitochondrial Medicine (C3M) is an initiative supported by the University of Pittsburgh Department of Medicine’s Division of Endocrinology and Metabolism, the Division of Cardiology, and the Vascular Medicine Institute. C3M‘s mission is to facilitate and initiate research to understand the contribution of metabolism and the mitochondria in disease pathology and physiology. Dr. Brett Kaufman is one of the co-directors of C3M. C3M also supports meetings like TriMAD Symposium and the Pittsburgh Lung Conference.

Brett Kaufman lab.
Vascular Medicine primary investigator and labs for stock, photographed in the Biomedical Science Tower, May 8, 2023
Vascular Medicine primary investigator and labs for stock, photographed in the Biomedical Science Tower, May 8, 2023
Vascular Medicine primary investigator and labs for stock, photographed in the Biomedical Science Tower, May 8, 2023
Vascular Medicine primary investigator and labs for stock, photographed in the Biomedical Science Tower, May 8, 2023
Vascular Medicine primary investigator and labs for stock, photographed in the Biomedical Science Tower, May 8, 2023